Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Abnormalities in mitochondrial metabolism have been linked to renal disease however, the precise mechanism underlying its involvement in immunoglobulin A nephropathy (IgAN) remains incompletely elucidated. The objective of this study was to ascertain the impact of biomarkers associated with mitochondrial metabolism on IgAN.
The data related to IgAN were obtained from public databases. The mitochondrial metabolism-related biomarkers in IgAN were identified through various bioinformatics approaches, including machine learning algorithms and expression validation. Subsequently, enrichment analysis and immune microenvironment analysis were conducted to explore biomarkers' potential mechanisms in IgAN. Additionally, single-cell RNA sequencing (scRNA-seq) analysis was performed to identify key cell types and clarify the expression dynamics of biomarkers. The expression levels of the biomarkers were validated via reverse transcription quantitative PCR (RT-qPCR).
Two robust biomarkers, CYP27B1 and PCK1, were consistently downregulated in IgAN across training and validation cohorts (P < 0.001), showing excellent diagnostic accuracy (AUC = 0.98–1.00). Both were co-enriched in oxidative phosphorylation and fatty-acid-metabolism pathways, indicating impaired mitochondrial bioenergetics. Immune microenvironment analysis revealed strong positive correlations of CYP27B1 and PCK1 with neutrophils and negative correlations with activated NK cells, linking metabolic dysregulation to immune activation. Single-cell analysis identified proximal tubular cells (PTCs) as the predominant cell population expressing these biomarkers. PCK1 expression increased at early differentiation stages and declined later, while CYP27B1 remained relatively stable. RT-qPCR confirmed significant downregulation of both biomarkers in IgAN samples, consistent with transcriptomic predictions.
Integrating bulk and single-cell transcriptomics with experimental validation, this study identifies CYP27B1 and PCK1 as novel mitochondrial metabolism-related biomarkers in IgAN and pinpoints PTCs as key pathological cell types. These findings highlight a mitochondrial-immune axis driving IgAN progression and provide promising targets for non-invasive diagnosis and metabolic intervention.
